Back to search
Vogt Koyanagi Harada Disease (VKH)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vogt Koyanagi Harada Disease (VKH) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Vogt Koyanagi Harada Disease (VKH) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Vogt-Koyanagi-Harada (VKH) disease is a rare autoimmune disorder characterized by bilateral ocular inflammation that may lead to serous retinal detachment and p…
Efficacy of monthly intravitreal anti-vascular endothelial growth factor (VEGF) associated to systemic immunosuppression in patients with Vogt-Koyanagi-Harada D…
The aim of this study is to evaluate the efficacy and safety of corticosteroidcombining noncorticosteroid systemic immunomodulatory therapy (NCSIT) for the trea…
VKH disease is a vision threatening condition.The investigators consider that ozurdex intravitreal implant is an effective line of treatment in recurrent VKH po…